Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PTT-4256 in Advanced Solid Tumors
NCT06634849Phase 2Recruiting
- Sponsor
- Pathios Therapeutics
- Start
- Nov 2024
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of PTT-4256 in solid tumor (advanced stage), sponsored by Pathios Therapeutics. Started Nov 2024; status: recruiting.
02
Drugs
PTT-4256
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT06634849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06634849.